Does DUPILUMAB Cause Injection site swelling? 9,582 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9,582 reports of Injection site swelling have been filed in association with DUPILUMAB (Dupixent). This represents 2.5% of all adverse event reports for DUPILUMAB.
9,582
Reports of Injection site swelling with DUPILUMAB
2.5%
of all DUPILUMAB reports
3
Deaths
135
Hospitalizations
How Dangerous Is Injection site swelling From DUPILUMAB?
Of the 9,582 reports, 3 (0.0%) resulted in death, 135 (1.4%) required hospitalization, and 2 (0.0%) were considered life-threatening.
Is Injection site swelling Listed in the Official Label?
Yes, Injection site swelling is listed as a known adverse reaction in the official FDA drug label for DUPILUMAB.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
CERTOLIZUMAB PEGOL (782)
Which DUPILUMAB Alternatives Have Lower Injection site swelling Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE